Find below a list of all Satellite Symposia of EANM’24.
The content presented on this page is constantly updated.
Symposium 1
ABX advanced chemical compounds Sunday, October 20, 2024 (13:15 - 14:45)
Hall X1-X4
Content/Abstracts/Speakers will be mentioned here as soon as confirmed.
Symposium 2
Siemens Healthineers Sunday, October 20, 2024 (13:15 - 14:45)
Hall Y10-Y12 (livestream available)
Content/Abstracts/Speakers will be mentioned here as soon as confirmed.
Symposium 3
Boston Scientific Sunday, October 20, 2024 (13:15 - 14:45)
Hall G2 (livestream available)
SIRT in action: Cutting-edge TheraSphere dosimetry for hepatic malignancies
- Maximizing HCC treatments with Therasphere: activity matters, not just dose (Dr Maccauro)
- Optimizing treatment planning for NETs and mCRC: dosimetry recommendations (Dr Braat)
- Enhancing mCRC Radioembolization Treatments: Dosimetry insights with Simplicit90Y Software and Multicenter experience (Dr Soydal)
Content/Abstracts/Speakers will be updated here as soon as confirmed.
Symposium 4
Telix Pharmaceuticals Sunday, October 20, 2024 (13:15 - 14:45)
Hall G1 (livestream available)
Content/Abstracts/Speakers will be mentioned here as soon as confirmed.
Symposium 5
OncoBeta GmbH Sunday, October 20, 2024 (13:15 - 14:45)
Hall Y1-Y3
Content/Abstracts/Speakers will be mentioned here as soon as confirmed.
Symposium 6
Curium Monday, October 21, 2024 (13:15 - 14:45)
Hall Y10-Y12 (livestream available)
Why is PSMA PET here to stay?
Our speakers who are leaders in the field of prostate cancer will share their clinical experience:
- Prof. Dr. Jochen Christoph Walz, Urologist
Department of Urology
Institut Paoli-Calmettes Cancer Centre
Marseille, France - Dr. Harun Ilhan, Nuclear Medicine Physician
Department of nuclear medicine
Die Radiologie
München, Germany - Dr. Gary Cook, Nuclear Medicine Physician
Department of Cancer Imaging
King’s College London
London, UK
Symposium summary:
Nowadays, prostate-specific membrane antigen (PSMA) positron emission tomography (PET) is taking a central role in the daily management of patients with prostate cancer.
Our speakers will focus on the role PSMA PET radiopharmaceuticals play in their practice – from the perspective of a urologist and nuclear medicine physician.
Symposium 7
United Imaging Healthcare Monday, October 21, 2024 (13:15 - 14:45)
Hall G2 (livestream available)
Content/Abstracts/Speakers will be mentioned here as soon as confirmed.
Symposium 8
GE Healthcare Monday, October 21, 2024 (13:15 - 14:45)
Hall G1
Shaping the future of the nuclear medicine department
Plenary presentations followed by a panel discussion
- Moderator: Prof K. Herrmann, Essen University hospital
- Dr. Arthur Braat, UMC Utrecht, Netherlands
- Prof. Mike Sathekge, NuMeRi, South Africa
- Prof. Andrei Iagaru, Stanford University, USA
Symposium 9
Spectrum Dynamics Monday, October 21, 2024 (13:15 - 14:45)
Hall Y1-Y3
Breaking Barriers in Digital SPECT Imaging
Content/Abstracts/Speakers will be mentioned here as soon as confirmed.
Symposium 10
Eli Lilly Tuesday, October 22, 2024 (13:15 - 14:45)
Hall Y10-Y12 (livestream available)
Content/Abstracts/Speakers will be mentioned here as soon as confirmed.
Symposium 11
Pfizer Tuesday, October 22, 2024 (13:15 - 14:45)
Hall G2 (livestream available)
Optimizing nuclear imaging for enhanced care in ATTR-CM
Meeting Objectives:
- Raise awareness among specialists about the key clinical red flags indicative of cardiac amyloidosis, emphasizing the importance of early recognition, referral and treatment
- Share clinical data and safety outcomes of tafamidis in the treatment of ATTR-CM, highlighting results from clinical trials and real-world applications
- Highlight best-practice guidelines on the use of cardiac scintigraphy in achieving an accurate diagnosis of ATTR-CM
- Share clinical experience on the practical application of cardiac scintigraphy in diagnosing ATTR-CM
| Timings | Presentation title | Suggested faculty (TBC) |
| 15 minutes | Understanding cardiac amyloidosis and the importance of early recognition and treatment | TBC |
| 20 minutes | Advanced imaging techniques and the role of non invasive diagnosis of ATTR-CM | TBC |
| 15 minutes | Navigating diagnostic complexities for cardiac scintigraphy in ATTR-CM | TBC |
| 10 minutes | Q&A | All, moderated by Chair |